Flagship's Vesalius launches with $75M to take AI into realm of common diseases
Artificial intelligence is a powerful tool for rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine learning can also be applied to common diseases, and the startup has launched with $75 million in committed financing.
Source: medcitynews.com